Clinical Trials Browser

Phase 2 × Terminated × Solid Tumor × Clear all

NCT05023655 2026-03-17

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT04617054 2026-01-21

Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT04276376 2025-12-01

ARIANES

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Phase 2 Terminated

2 enrolled 4 charts

Other solid neoplasm

Solid Tumor

NCT04827576 2025-05-08

ELEVATELung&UC

Phase 2 Terminated

106 enrolled 22 charts

Other solid neoplasm

Solid Tumor

NCT03834220 2024-02-07

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

Phase 2 Terminated

63 enrolled 18 charts

Other solid neoplasm

Solid Tumor

NCT04071756 2024-02-07

Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

Phase 2 Terminated

8 enrolled 12 charts

Other solid neoplasm

Solid Tumor

NCT03600467 2021-03-05

START

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT02950103 2019-09-30

Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT00982657 2015-11-20

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Phase 2 Terminated

34 enrolled 10 charts

Other solid neoplasm

Solid Tumor